The North America liver disease treatment market accounted for $6,970 million in 2019, and is expected to reach $8,318 million by 2027, registering a CAGR of 5.2% from 2020 to 2027.
Alcoholic hepatitis is referred as an acute but destructive form of liver disease that is characterized by increased bilirubin level. The normal bilirubin level for a healthy adult ...
